168 related articles for article (PubMed ID: 32768930)
1. Cisplatin treatment modulates Annexin A1 and inhibitor of differentiation to DNA 1 expression in cervical cancer cells.
Prates J; Moreli JB; Gimenes AD; Biselli JM; Pires D'Avila SCG; Sandri S; Farsky SHP; Rodrigues-Lisoni FC; Oliani SM
Biomed Pharmacother; 2020 Sep; 129():110331. PubMed ID: 32768930
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of annexin A1 during the progression of cervical neoplasia.
Wang LD; Yang YH; Liu Y; Song HT; Zhang LY; Li PL
J Int Med Res; 2008; 36(4):665-72. PubMed ID: 18652761
[TBL] [Abstract][Full Text] [Related]
3. [Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
Liao YD; Xu H; Han Q; Lei J; Zhang YY; Wang ZH
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):360-4. PubMed ID: 17892132
[TBL] [Abstract][Full Text] [Related]
4. ANXA1Ac₂₋₂₆ peptide reduces ID1 expression in cervical carcinoma cultures.
Prates J; Franco-Salla GB; Dinarte Dos Santos AR; da Silva WA; da Cunha BR; Tajara EH; Oliani SM; Rodrigues-Lisoni FC
Gene; 2015 Oct; 570(2):248-54. PubMed ID: 26072160
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
[TBL] [Abstract][Full Text] [Related]
6. IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer.
Lu D; Yang X; Jiang NY; Woda BA; Liu Q; Dresser K; Mercurio AM; Rock KL; Jiang Z
Am J Surg Pathol; 2011 Nov; 35(11):1638-45. PubMed ID: 21997684
[TBL] [Abstract][Full Text] [Related]
7. Association of serum annexin A1 with treatment response and prognosis in patients with esophageal squamous cell carcinoma.
Han GH; Lu KJ; Huang JX; Zhang LX; Dai SB; Dai CL
J Cancer Res Ther; 2018 Sep; 14(Supplement):S667-S674. PubMed ID: 30249885
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of Dyrk1b in the specimens and cells of cervical lesions].
Lin J; Zhang P; Pang L; Chen J; Sun W; Qi W; Lyu Y; Guan H; Gao J
Zhonghua Fu Chan Ke Za Zhi; 2016 Jan; 51(1):40-5. PubMed ID: 26899006
[TBL] [Abstract][Full Text] [Related]
9. Cell-cycle analysis and apoptosis-associated proteins in cervical lesions of Brazilian women.
Dobo C; Oshima CT; De Oliveira Lima F; Gomes TS; Stávale JN; Arias V; Ribeiro DA; Focchi GR
Anticancer Res; 2014 Jun; 34(6):2789-96. PubMed ID: 24922640
[TBL] [Abstract][Full Text] [Related]
10. Sex-determining region Y-related high mobility group box (SOX)-2 is overexpressed in cervical squamous cell carcinoma and contributes cervical cancer cell migration and invasion in vitro.
Chang X; Zhang J; Huang C; Pang X; Luo Q; Zhang H; Zhang S
Tumour Biol; 2015 Sep; 36(10):7725-33. PubMed ID: 25935536
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
12. Effect of Annexin A1 gene on the proliferation and invasion of esophageal squamous cell carcinoma cells and its regulatory mechanisms.
Han G; Lu K; Huang J; Ye J; Dai S; Ye Y; Zhang L
Int J Mol Med; 2017 Feb; 39(2):357-363. PubMed ID: 28035369
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner.
Zhao Y; Luo A; Li S; Zhang W; Chen H; Li Y; Ding F; Huang F; Liu Z
J Biol Chem; 2016 Mar; 291(13):6831-42. PubMed ID: 26858249
[TBL] [Abstract][Full Text] [Related]
14. [Effect of extracellular signal-regulated kinas 1/2 expression and HPV16 infection and their interaction in progression of cervical cancerization].
Fan SL; Ding L; Ren ZY; Chen X; Sun XS; Li CC; Liu CL; Jia WL; Li QL; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):96-101. PubMed ID: 28100386
[No Abstract] [Full Text] [Related]
15. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro.
Pang X; Zhang Y; Zhang S
Oncol Rep; 2017 Feb; 37(2):831-840. PubMed ID: 28000879
[TBL] [Abstract][Full Text] [Related]
17. Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study.
Reesink-Peters N; Hougardy BM; van den Heuvel FA; Ten Hoor KA; Hollema H; Boezen HM; de Vries EG; de Jong S; van der Zee AG
Gynecol Oncol; 2005 Mar; 96(3):705-13. PubMed ID: 15721415
[TBL] [Abstract][Full Text] [Related]
18. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
Oshi M; Tokumaru Y; Mukhopadhyay S; Yan L; Matsuyama R; Endo I; Takabe K
Cells; 2021 Mar; 10(3):. PubMed ID: 33804148
[TBL] [Abstract][Full Text] [Related]
19. Role of Annexin A1 in Squamous Cell Lung Cancer Progression.
Elakad O; Li Y; Gieser N; Yao S; Küffer S; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Ströbel P; Bohnenberger H
Dis Markers; 2021; 2021():5520832. PubMed ID: 33959206
[TBL] [Abstract][Full Text] [Related]
20. ANXA1 silencing increases the sensitivity of cancer cells to low-concentration arsenic trioxide treatment by inhibiting ERK MAPK activation.
Zhang X; Li X; Li X; Zheng L; Lei L
Tumori; 2015; 101(4):360-7. PubMed ID: 25983101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
